Salute e Benessere

IoT in Healthcare Market to Surpass USD 594.5 Billion by 2035 -- AI & Smart…

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/iot-in-healthcare-market-1232/request-sample The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @https://www.vantagemarketresearch.com/iot-in-healthcare-market-1232/request-sample Free Sample Includes: Technological & Industry Momentum Unlocking Opportunities for Decision-Makers ...
PR Newswire
07/10/2025

Journal of Applied Cosmetology – A New Issue That Redefines Advanced Cosmetology

W.H.A. Publishing House
07/10/2025

Peli BioThermal Announces Acquisition to Expand Cold Chain Logistics Solutions…

This acquisition strengthens Peli BioThermal's ability to deliver a full spectrum of cold chain solutions, providing a more complete range of options to existing customers while creating opportunities to engage with new pharmaceutical, biopharmaceutical, and clinical supply customers. Current Evo users will gain added convenience and integration by sourcing solutions directly through Peli BioThermal, while the Evo product line itself will benefit from accelerated development, innovation, and…
PR Newswire
07/10/2025

Multi-Plex Immunoassays Market to Reach US$ 6.90 Billion by 2033 as Precision…

With rising demand in oncology, infectious diseases, autoimmune conditions, and personalized medicine, the adoption of multi-plex platforms is accelerating across hospitals, diagnostic labs, and biopharma research institutes. Global leaders such as Thermo Fisher Scientific, Bio-Rad, QIAGEN, Merck KGaA, and BD are strengthening portfolios with advanced consumables, reagents, and integrated digital platforms. With rising demand inoncology, infectious diseases, autoimmune conditions, and...
PR Newswire
07/10/2025

LILYSILK Renews Partnership with NBCF, Expands Caring Collection to Support…

These contributions have helped fund breast health education for 32 women, provide 23 mammograms, support 75 trained patient navigators, and provide personalized navigation services to 123 patients. The funds also supported 204 HOPE Kit Packing Party events held at NBCF headquarters, enabled 1,558 volunteers to serve in various program roles, and delivered 11 HOPE Kits to women undergoing treatment. These outcomes reflect the tangible, life-affirming impact behind every Caring Collection…
PR Newswire
07/10/2025

Suvoda Expands Clinical Trial Patient Travel Access Across the EU With Bolt…

By providing a low-cost, reliable alternative to traditional car services while maintaining high standards of privacy and data security, this partnership will improve patient access across diverse trial populations. By providing a low-cost, reliable alternative to traditional car services while maintaining high standards of privacy and data security, this partnership will improve patient access across diverse trial populations. "This partnership is built on Suvoda's and Bolt Business's...
PR Newswire
07/10/2025

An Era Where Meditation Becomes a Quantifiable Achievement -- Japan's First…

For the first time, audiences witnessed meditation in real time, as brain activity, attention, self-awareness and inner silence were displayed as quantifiable data on screen. For the first time, audiences witnessed meditation in real time, as brain activity, attention, self-awareness and inner silence were displayed as quantifiable data on screen. Technology × Architecture × Nature —Kengo Kumaand All Here's Meditation Capsule Unveiled The afternoon began with a presentation by...
PR Newswire
07/10/2025

Metabolon's Metabolomics Services Now Cited in More Than 4,000 Peer-Reviewed…

Publications referencing Metabolon's platform and results have appeared in many of the world's most respected journals, including Nature, Nature Medicine, Nature Genetics, Cell, and the Proceedings of the National Academy of Sciences (PNAS). These peer-reviewed citations underscore the increasing recognition of metabolomics as an essential component of multiomics research. Publications referencing Metabolon's platform and results have appeared in many of the world's most respected journals,...
PR Newswire
07/10/2025

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- USA News Group News Commentary – Major pharmaceutical companies are unveiling breakthrough cancer data at the European Society for Medical Oncology Congress taking place October 17-21 in Berlin[1], while the global cancer immunotherapy market reached $137.70 billion in 2024 and analysts project explosive growth toward $261.74 billion by 2033[2]. The timing reflects a critical inflection point as HHS doubled federal funding for its Childhood Cancer Data…
PR Newswire
07/10/2025

T-knife Therapeutics Presents Preclinical Data Highlighting the Transformative…

--Integrating a computational workflow that leverages multi-omics data with a proprietary, humanized in vivo screening platform, T-knife identified highly immunogenic solid-tumor antigens not previously recognized as functional-- T-knife’s lead product, TK-6302, is a supercharged PRAME T cell receptor therapy that is advancing towards the clinic, with a Clinical Trial Application (CTA) planned to be filed in Q4 2025SAN FRANCISCO and BERLIN, Oct.07, 2025(GLOBE NEWSWIRE) --...
Nasdaq GlobeNewswire
07/10/2025

ZEISS expands DORC portfolio and further strengthens digital footprint with…

"ZEISS continues to be at the forefront of optical and digital innovation, advancing our clinical workflows to be more efficient and empowering for doctors and surgeons around the world to deliver more precise and personalized care for their patients," says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. "ZEISS continues to be at the forefront of optical and digital innovation, advancing our clinical workflows to be more efficient…
PR Newswire
07/10/2025

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – Major pharmaceutical companies presenting at the European Society for Medical Oncology Congress October 17-21[1] are unveiling pivotal survival data[2] and late-breaking lung cancer[3] results that demonstrate how diverse mechanisms are succeeding where traditional approaches stalled, while regulatory agencies issued multiple September approvals spanning gene therapies, bispecifics, and novel delivery systems[4]. The…
PR Newswire
07/10/2025

Esaote enters the field of neurosurgery by presenting an innovative…

I-Genius is the result of Esaote’s research and collaboration with neurosurgeons. The results achieved using MRI systems in brain glioma surgery were presented at EANS annual Congress held in ViennaThe medical and scientific neurosurgical community gathered at the Symposium “Expertise Meets lnnovation: why the I-Genius MRI solution will Change Neurosurgery”VIENNA, Oct.07, 2025(GLOBE NEWSWIRE) --Esaote,a leading Italian innovator in medical imaging – ultrasound, dedicated...
Nasdaq GlobeNewswire
07/10/2025

Lilly and Leading Alzheimer's Disease Experts Call for Urgent Action to Close…

"We find ourselves at a critical moment, where the decisions made now will shape the future of AD care in Europe," reflected Professor Lutz Frölich, Head of the Department of Geriatric Psychiatry, Central Institute of Mental Health and Full Professor, Medical Faculty Mannheim, University of Heidelberg, Germany. "Science has equipped us with the solutions to manage AD more effectively in its early stages, potentially reducing the disease burden. But this will only be possible if we…
PR Newswire
07/10/2025

Essence SmartCare's AI-Driven Care@Home™ Communicator 2.0 Earns Reimbursement…

Expanding Global Relevance of Reimbursable Telecare Expanding Global Relevance of Reimbursable Telecare The GKV certification affirms the product's compliance with rigorous standards for safety, usability, and health impact. While the certification is country-specific, its implications are international: governments and insurers worldwide are moving toward outcome-driven care models that emphasize early intervention and remote assistance—areas where theCommunicator 2.0excels. Part...
PR Newswire
07/10/2025

Cardinal Health launches a new all-in-one solution for deep vein thrombosis and…

"We're excited to bring the new Kendall SCD SmartFlow™ system to our international customers, which offers consistent, effective, and reliable compression therapy," said Frederic LeRoy, VP of International Marketing. "Its new indication related to venous stasis addresses symptoms that can significantly impact patients with compromised blood flow. This innovative product is also designed to help streamline clinical workflows, allowing healthcare professionals to dedicate more time…
PR Newswire
07/10/2025

Esaote enters the field of neurosurgery by presenting an innovative…

VIENNA, Oct. 7, 2025 /PRNewswire/ -- Esaote, a leading Italian innovator in medical imaging – ultrasound, dedicated magnetic resonance and medical IT – presented I–Genius, an innovative open MRI system designed to provide real time checks during glioma surgery, on the occasion of the 25th EANS - European Association of Neurosurgical Societies - Annual Congress held in Vienna on 5-9 October. VIENNA , Oct. 7, 2025 /PRNewswire/ --Esaote,a leading Italian innovator in medical imaging –...
PR Newswire
07/10/2025

Resolution Therapeutics to present EMERALD study design at the British…

Professor Jonathan Fallowfield, Chair of Translational Liver Research and Principal Investigator at the University of Edinburgh, Honorary Consultant Hepatologist at the Royal Infirmary of Edinburgh, will present a poster detailing the study design for the Phase I/II EMERALD study of RTX001, a novel autologous engineered macrophage cell therapy. The study is a multicentre, single-arm, first-in-human, open-label study designed to evaluate the safety and efficacy of RTX001 in patients who have had…
PR Newswire
07/10/2025

Optimum Strategic Communications to Host 17th Annual Healthcare Investor…

Returning to this year's event – by popular demand – is Optimum's 'Investor speed dating' morning, which brings together exciting early-stage companies and leading life sciences investors. Returning to this year's event – by popular demand – is Optimum's'Investor speed dating'morning, which brings together exciting early-stage companies and leading life sciences investors. Mary Clark, CEO of Optimum Strategic Communications, commented: "Despite the tough market conditions we have...
PR Newswire
07/10/2025

Blue Earth Therapeutics Presents Modelling Data Supporting Early Dose…

The model assessed three dosing scenarios, all with dosing at six-weekly intervals: The model assessed three dosing scenarios, all with dosing at six-weekly intervals: The model extrapolated the reductions in tumour-absorbed radiation doses across each of cycles 4-8 using data available from cycles 1-3 and predicted the cumulative tumour absorbed radiation dose for each dosing scenario. The results showed that the front-loaded regimens both increase tumour-absorbed radiation dose; by 15%...
PR Newswire
07/10/2025

UAE Residents embrace proactive, tech-driven, and sustainable healthcare…

Proactive Choices and Digital Health Adoption Proactive Choices and Digital Health Adoption UAE residents are emerging as one of the region's most health-conscious and future-ready populations. A notable 92% of respondents place high importance on taking control of their health and well-being, reflecting a clear shift toward personal accountability. Growing confidence and optimism in digitalisation and artificial intelligence (AI) The study reveals that 77% of residents are...
PR Newswire
07/10/2025

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the…

Poster presentation:Title:Circularization of Single-Stranded DNA Donor Template Unleashes the Power of Non-Viral Gene Delivery for Long-Term HSCs editing Presenter : Julien Valton, Ph.D., Vice President Gene Therapy at Cellectis Date/Time:Wednesday, October 8, 2025 from 2:00 p.m. to 3:30 p.m. CET Posternumber: P0439Over the past decade, non-viral DNA template delivery has been used with engineered nucleases to target single-stranded DNA sequences in hematopoietic stem...
Nasdaq GlobeNewswire
07/10/2025

Beactica conducts first advisory meeting with the Swedish Medical Products…

About BEA-17 About BEA-17 BEA-17 is a first-in-class small molecule targeted degrader of lysine demethylase 1 (LSD1) and its co-factor CoREST. In syngeneic animal models of cancer, the compound has shown promising potentiation of immune-modulating treatments in several cancer forms, including anti-PD1 checkpoint inhibitors in colon cancer (CT26) and standard of care (temozolomide and radiation) in glioblastoma (GL261). Pharmacokinetic studies of BEA-17 show good blood-brain-barrier...
PR Newswire
07/10/2025

Kadisco General Hospital and MindHYVE.ai™ Sign Strategic MoU to Transform…

Three Pillars of Collaboration Three Pillars of Collaboration Under the MoU, Kadisco and MindHYVE.ai™ will jointly explore pilot programs across three key tracks: Ethiopiafaces one of the lowest doctor-to-patient ratios inAfrica, with fewer than 1.5 physicians per 10,000 people, making access to quality care a critical challenge. Kadisco General Hospital already manages more than 50,000 patient visits and 15,000 emergency cases annually, and through its partnership with MindHYVE...
PR Newswire
07/10/2025
Altri  Comunicati